Model
Edge
Alnylam Pharmaceuticals, Inc.
0001219016
Filing type
144
Filing date
May 14, 2025
Updated
May 15, 2025 ยท 2:03 PM
Copy reference
Filing
144
Notice of Proposed Sale of Securities